title: [Glycaemic management in type 1 and 2 diabetes patients undergoing interventional cardiology procedures. Heart and Diabetes Working Group. Sociedad Espan˜ola de Cardiologı´a. Sociedad Espan˜ola de Diabetes].
abstract: Despite the growing number of therapeutic alternatives available as well as general reviews and treatment guidelines for the treatment of diabetes, physicians are often left without a clear pathway of therapy to follow in specific clinical contexts such as interventional cardiology. The present document proposes a consensus treatment algorithm, based both on a critical appraisal of evidence from recent clinical trials and on value judgements supported by the authors' collective clinical knowledge and experience, in an attempt to guide practitioners when choosing the most appropriate alternatives in the context of glycemic management in type 1 and 2 diabetic patients scheduled to undergo interventional cardiology procedures in a haemodynamic laboratory.
authors.affiliation: Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Madrid, Spain. angelesalonsog@secardiologia.es
authors.forename: Angeles
authors.initials: A
authors.lastname: Alonso-García
authors.forename: Raúl
authors.initials: R
authors.lastname: Moreno Gómez
authors.forename: Faustino
authors.initials: F
authors.lastname: Miranda Guardiola
authors.forename: Sara
authors.initials: S
authors.lastname: Artola-Menéndez
authors.forename: Arturo
authors.initials: A
authors.lastname: Lisbona-Gil
mesh_terms: D000140:Acidosis, Lactic / Q000139:chemically induced / Q000517:prevention & control; D000465:Algorithms; D001786:Blood Glucose / Q000032:analysis*; D006348:Cardiac Surgical Procedures; D003287:Contrast Media / Q000009:adverse effects / Q000493:pharmacokinetics; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D019468:Disease Management; D006801:Humans; D006943:Hyperglycemia / Q000209:etiology / Q000517:prevention & control; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007431:Intraoperative Complications / Q000517:prevention & control; D017613:Iodine Compounds / Q000009:adverse effects / Q000493:pharmacokinetics; D007674:Kidney Diseases / Q000150:complications; D017202:Myocardial Ischemia / Q000150:complications / Q000601:surgery; D011183:Postoperative Complications / Q000517:prevention & control
chemical_list: D001786:Blood Glucose; D003287:Contrast Media; D007004:Hypoglycemic Agents; D007328:Insulin; D017613:Iodine Compounds